Fumihiko Urabe, MD, discusses a study for which he was the lead author, entitled “Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer.” This study investigated the potential use of micro-RNA (miRNA) as an improved biomarker for detecting prostate cancer. He details how his team found 16 miRNAs related to prostate cancer which displayed high specificity and sensitivity in detection, and how extracting miRNA is preferable to the risks and invasiveness of prostate biopsy.Read More
Fumihiko Urabe, MD
The Jikei University School of Medicine
Fumihiko Urabe, MD, is a Clinical Associate in the Department of Urology at the Jikei University School of Medicine, Tokyo, Japan. He graduated from the Jikei University School of Medicine in 2012 and completed his residency at the same institution. He was a research fellow (Professor Takahiro Ochiya’s Lab) in National Cancer Center, Tokyo, Japan from 2016 to 2018. His research focuses on cancer biology, microRNAs (miRNAs), liquid biopsy, exosomes and extracellular vesicles in urological cancers. Recently, his research group focused on serum miRNA and launched a national project in Japan, entitled "Development and Diagnostic Technology for Detection of miRNA in Body Fluids." The aims of this project are to standardize platforms for evaluation of serum miRNA profiles of 13 types of human cancers, including prostate cancer and bladder cancer, using large sample sets (N>40,000). As the lead author, he published the results of these urological cancers in 2019. Now his group has started collecting fresh samples prospectively and is planning to validate his retrospective results within three years.